Analysts predict that DENTSPLY SIRONA Inc (NASDAQ:XRAY) will announce $0.45 earnings per share (EPS) for the current quarter, Zacks reports. Seven analysts have made estimates for DENTSPLY SIRONA’s earnings. The lowest EPS estimate is $0.41 and the highest is $0.53. DENTSPLY SIRONA posted earnings per share of $0.49 in the same quarter last year, which indicates a negative year over year growth rate of 8.2%. The company is expected to announce its next quarterly earnings report on Friday, May 1st.
On average, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.58 per share for the current financial year, with EPS estimates ranging from $2.39 to $2.67. For the next financial year, analysts forecast that the firm will post earnings of $2.95 per share, with EPS estimates ranging from $2.84 to $3.12. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that cover DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Monday, March 2nd. The medical instruments supplier reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.02). DENTSPLY SIRONA had a return on equity of 10.76% and a net margin of 6.52%. The business had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.09 billion. During the same period in the prior year, the company earned $0.58 EPS. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year.
XRAY has been the subject of several recent analyst reports. BidaskClub downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Wednesday, March 4th. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $61.00 to $57.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 3rd. Barclays reaffirmed a “hold” rating and set a $64.00 price target on shares of DENTSPLY SIRONA in a research report on Sunday, January 19th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $60.00 price target on the stock in a research report on Tuesday, December 10th. Finally, HC Wainwright reaffirmed a “neutral” rating and set a $51.00 price target (down previously from $60.00) on shares of DENTSPLY SIRONA in a research report on Tuesday, March 3rd. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $55.88.
Shares of DENTSPLY SIRONA stock traded up $4.40 during trading hours on Thursday, hitting $39.40. 3,826,428 shares of the company’s stock traded hands, compared to its average volume of 3,683,273. The stock has a 50 day simple moving average of $47.99 and a 200-day simple moving average of $53.79. The company has a quick ratio of 1.44, a current ratio of 2.01 and a debt-to-equity ratio of 0.30. The company has a market cap of $7.49 billion, a PE ratio of 33.68, a PEG ratio of 1.22 and a beta of 0.96. DENTSPLY SIRONA has a twelve month low of $31.58 and a twelve month high of $60.87.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 10th. Investors of record on Friday, March 27th will be paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date is Thursday, March 26th. DENTSPLY SIRONA’s dividend payout ratio is 16.33%.
Hedge funds have recently added to or reduced their stakes in the stock. Rational Advisors LLC boosted its position in shares of DENTSPLY SIRONA by 27.3% during the 4th quarter. Rational Advisors LLC now owns 859 shares of the medical instruments supplier’s stock valued at $49,000 after acquiring an additional 184 shares in the last quarter. Meeder Asset Management Inc. raised its stake in shares of DENTSPLY SIRONA by 0.6% during the fourth quarter. Meeder Asset Management Inc. now owns 32,539 shares of the medical instruments supplier’s stock worth $1,843,000 after buying an additional 208 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of DENTSPLY SIRONA by 2.1% during the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 14,719 shares of the medical instruments supplier’s stock worth $832,000 after buying an additional 300 shares during the last quarter. Nisa Investment Advisors LLC raised its stake in shares of DENTSPLY SIRONA by 0.5% during the fourth quarter. Nisa Investment Advisors LLC now owns 60,811 shares of the medical instruments supplier’s stock worth $3,441,000 after buying an additional 304 shares during the last quarter. Finally, Fieldpoint Private Securities LLC raised its stake in shares of DENTSPLY SIRONA by 54.9% during the fourth quarter. Fieldpoint Private Securities LLC now owns 987 shares of the medical instruments supplier’s stock worth $55,000 after buying an additional 350 shares during the last quarter. 95.61% of the stock is owned by institutional investors and hedge funds.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Featured Story: Google Finance Portfolio
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.